$BGNE BeiGene, Ltd. Insider Trading Week 50/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BeiGene, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BeiGene, Ltd. in week 50/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Option Exercise | M | 2.24 | 131,833 | 295,306 | 820,000 | |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Option Exercise | M | 2.24 | 128,167 | 287,094 | 951,833 | |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 135.54 | 611 | 82,816 | 0 | 611 to 0 (-100.00 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 134.81 | 3,600 | 485,316 | 611 | 4.2 K to 611 (-85.49 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 133.88 | 2,402 | 321,585 | 4,211 | 6.6 K to 4.2 K (-36.32 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 132.70 | 1,897 | 251,735 | 6,613 | 8.5 K to 6.6 K (-22.29 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 131.74 | 1,631 | 214,860 | 8,510 | 10.1 K to 8.5 K (-16.08 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Buy | M | 29.10 | 10,141 | 295,103 | 10,141 | 0 to 10.1 K |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 136.93 | 480 | 65,726 | 0 | 480 to 0 (-100.00 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 136.25 | 2,296 | 312,818 | 480 | 2.8 K to 480 (-82.71 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 135.05 | 778 | 105,065 | 2,776 | 3.6 K to 2.8 K (-21.89 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 133.81 | 1,005 | 134,479 | 3,554 | 4.6 K to 3.6 K (-22.04 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 132.91 | 1,700 | 225,953 | 4,559 | 6.3 K to 4.6 K (-27.16 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 131.80 | 2,700 | 355,852 | 6,259 | 9 K to 6.3 K (-30.14 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Sell | S | 130.37 | 900 | 117,331 | 8,959 | 9.9 K to 9 K (-9.13 %) |
| Dec 19 2018 | BGNE | BeiGene, Ltd. | Peterson Amy C. | CMO, Immuno-oncolog ... | Buy | M | 29.10 | 9,859 | 286,897 | 9,859 | 0 to 9.9 K |